APEX was founded by CEO and president Christopher Banas, chairman of the board Murray Penner, MD, chief medical officer Greg Berlet, MD, and chief innovation officer Stephen Brigido, DPM, according to a May 7 press release.
The team has four decades of combined experience in product development and has collectively launched over 200 products, generating a cumulative revenue of $3 billion.
APEX will drive novel solutions in fixation hardware, mid-foot arthrodesis, mid-foot arthroplasty and more. It already has 12 pending patents in the U.S. and overseas, as well as 73 invention disclosures.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
